EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted protein degradation by KLHDC2 ligands identified by high-throughput screening

Han Zhou, Tonglian Zhou, Wenli Yu, Liping Liu, Yeonjin Ko, Kristen A Johnson, Ian A Wilson, Peter G Schultz, Michael J Bollong iD

eLife · 16.06.2025 · 14

DOI: 10.7554/elife.106844 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 16.06.2025. Verfasst von Han Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Scripps Research, La Jolla, United States. Hauptthemen laut MEDLINE: Proteolysis, High-Throughput Screening Assays, Ubiquitin-Protein Ligases, Transcription Factors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteolysis-targeting chimeras (PROTACs) enable the selective and sub-stoichiometric elimination of pathological proteins, yet only two E3 ligases are routinely used for this purpose. Here, we expand the repertoire of PROTAC-compatible E3 ligases by identifying a novel small molecule scaffold targeting the ubiquitin E3 ligase KLHDC2 using a fluorescence polarization-based high-throughput screen. We highlight the utility of this ligand with the synthesis of PROTACs capable of potently degrading BRD4 in cells. This work affords additional chemical matter for targeting KLHDC2 and suggests a practical approach for identifying novel E3 binders by high-throughput screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteolysisHigh-Throughput Screening AssaysUbiquitin-Protein LigasesTranscription FactorsHumansLigandsCell Cycle ProteinsNuclear ProteinsBromodomain Containing Proteins

Stichwörter der Autor:innen

E3 ligaseKLHDC2PROTACbiochemistrychemical biologyhigh-throughput screeninghuman

Substanzen

Ubiquitin-Protein LigasesLigandsBRD4 protein, humanCell Cycle ProteinsTranscription FactorsNuclear ProteinsBromodomain Containing Proteins

Autor:innen und Institutionen

  • Department of Chemistry, Scripps Research, La Jolla, United States.
  • Department of Integrative Structural and Computational Biology, Scripps Research, La Jolla, United States.
  • Chemical & Biological Integrative Research Center, Korea Institute of Science and Technology, Seoul, Republic of Korea.
  • Department of Biology, Calibr-Skaggs at Scripps Research, La Jolla, United States.

ORCID-Profile: Michael J Bollong

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Zhou, H., Zhou, T., Yu, W., Liu, L., Ko, Y., Johnson, K. A., Wilson, I. A., Schultz, P. G., & Bollong, M. J. (2025). Targeted protein degradation by KLHDC2 ligands identified by high-throughput screening. eLife, 14. https://doi.org/10.7554/elife.106844

Vancouver

Zhou H, Zhou T, Yu W, Liu L, Ko Y, Johnson KA, et al. Targeted protein degradation by KLHDC2 ligands identified by high-throughput screening. eLife. 2025;14. doi:10.7554/elife.106844

BibTeX
@article{Zhou2025,
  author = {Zhou, Han and Zhou, Tonglian and Yu, Wenli and Liu, Liping and Ko, Yeonjin and Johnson, Kristen A and Wilson, Ian A and Schultz, Peter G and Bollong, Michael J},
  title = {Targeted protein degradation by KLHDC2 ligands identified by high-throughput screening},
  journal = {eLife},
  year = {2025},
  volume = {14},
  doi = {10.7554/elife.106844}
}
Kostenlos starten →